149.25
price up icon0.69%   1.03
after-market Dopo l'orario di chiusura: 150.00 0.75 +0.50%
loading

Natera Inc Borsa (NTRA) Ultime notizie

pulisher
Mar 17, 2025

Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra

Mar 17, 2025
pulisher
Mar 17, 2025

Is Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires? - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Strong Growth Trajectory Despite Stretched Valuation Metrics (NASDAQ:NTRA) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Natera Inc.: Strong Execution in Revenue Per Test Powering Our Optimism! - Smartkarma

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Solid Execution, Pricey Stock (NASDAQ:NTRA) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time - Seeking Alpha

Mar 17, 2025
pulisher
Mar 16, 2025

Natera Sees Unusually Large Options Volume (NASDAQ:NTRA) - Defense World

Mar 16, 2025
pulisher
Mar 15, 2025

RBC Capital initiates Exact Sciences with Sector Perform, Natera with Outperform - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA - Business Wire

Mar 15, 2025
pulisher
Mar 15, 2025

Natera director Marcus Gail Boxer sells $590,773 in stock By Investing.com - Investing.com South Africa

Mar 15, 2025
pulisher
Mar 15, 2025

Natera executive chairman sells $7.39 million in stock By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 14, 2025

Natera director Marcus Gail Boxer sells $590,773 in stock - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Natera executive chairman sells $7.39 million in stock - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value - Simply Wall St

Mar 14, 2025
pulisher
Mar 14, 2025

Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board - Simply Wall St

Mar 13, 2025
pulisher
Mar 13, 2025

RBC Initiates Natera at Outperform With $251 Price Target -March 13, 2025 at 06:44 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 12, 2025

Natera initiated with an Outperform at RBC Capital - MSN

Mar 12, 2025
pulisher
Mar 12, 2025

Natera Appoints Monica Bertagnolli to Board of Directors - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Minimal Residual Disease Market Expected to rise, 2032 | Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, Amgen Inc., expected to boost the market - Barchart

Mar 12, 2025
pulisher
Mar 11, 2025

Natera at Leerink’s Global Healthcare Conference: Strategic Growth Insights - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Natera's Stock Rebounds Amid Market VolatilityNews and Statistics - IndexBox, Inc.

Mar 11, 2025
pulisher
Mar 11, 2025

How Do Investors Really Feel About Natera? - Benzinga

Mar 11, 2025
pulisher
Mar 11, 2025

NTRA Shares Rise After Market Rebound - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

Why Is Natera (NTRA) Stock Soaring Today - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

Natera (NASDAQ:NTRA) Upgraded at StockNews.com - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Natera launches HEROES trial for breast cancer treatment - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Natera launches HEROES trial for breast cancer treatment By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Natera enrolls first patients in HEROES clinical trial Metastatic HER2+ BC - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Natera Begins Major Clinical Trial for Breast Cancer Therapy Management - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

Non-invasive Prenatal Testing (NIPT) Market Growth and Future - openPR

Mar 10, 2025
pulisher
Mar 09, 2025

Natera damages blow; Ozempic patent gold rush; H&M IP strategy; Tesla loses Avanci 5G appeal; International Women’s Day; plus much more - IAM

Mar 09, 2025
pulisher
Mar 09, 2025

Natera, Inc. (NASDAQ:NTRA) Stake Increased by Smartleaf Asset Management LLC - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Solomon Moshkevich Sells 6,000 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Steven Leonard Chapman Sells 87,272 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Natera, Inc. (NASDAQ:NTRA) Position Decreased by US Bancorp DE - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Natera, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 07, 2025

Natera president sells $859,734 in company stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Natera president sells $859,734 in company stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Natera Executives Conduct Significant Stock Sales - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Morgan Stanley Boosts Natera (NASDAQ:NTRA) Price Target to $185.00 - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Natera CEO Steven Chapman sells $12.5 million in stock - Investing.com

Mar 07, 2025
pulisher
Mar 06, 2025

Piper Sandler Forecasts Strong Price Appreciation for Natera (NASDAQ:NTRA) Stock - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Natera Set to Continue Upside Surprises During 2025, Beyond, Morgan Stanley Says - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Natera price target raised to $185 from $176 at Morgan Stanley - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Natera, Inc. - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Natera’s Strong Financial Performance and Growth Potential Reinforce Buy Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Private Advisor Group LLC Has $397,000 Stock Position in Natera, Inc. (NASDAQ:NTRA) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Natera (NASDAQ:NTRA) Sees Large Volume Increase Following Analyst Upgrade - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

USPTO issues Natera new patent related to testing of ctDNA - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Natera Granted US Patent for Testing Single Nucleotide Variants -March 04, 2025 at 08:05 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

Natera Full Year 2024 Earnings: Beats Expectations - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Natera’s Strong Market Position and Growth Potential Justify Buy Rating - TipRanks

Mar 04, 2025
diagnostics_research DGX
$173.48
price up icon 1.95%
diagnostics_research LH
$240.43
price up icon 0.38%
diagnostics_research WAT
$378.92
price up icon 0.47%
diagnostics_research MTD
$1,235.02
price up icon 0.39%
diagnostics_research IQV
$184.90
price down icon 0.16%
Capitalizzazione:     |  Volume (24 ore):